| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $58.3M | -37.7% |
| Cost of Revenue | $48.4M | -34.9% |
| Gross Profit | $9.9M | -48.7% |
| R&D Expense | $14.2M | +703.3% |
| SG&A Expense | $12.4M | +49.7% |
| Operating Income | -$33.6M | -6657.3% |
| Pre-tax Income | -$33.4M | — |
| Income Tax | $226K | -39.6% |
| Net Income | -$33.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.3M | -43.1% |
| Accounts Receivable | $4.3M | -82.9% |
| Inventory | $10.6M | +63.0% |
| Current Assets | $32.2M | -26.5% |
| Total Assets | $39.7M | -29.1% |
| Current Liabilities | $43.7M | +36.1% |
| Total Liabilities | $45.4M | +34.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | -109.4% |
| Capital Expenditures | $214K | +494.4% |
| Investing Cash Flow | -$214K | -494.4% |
| Financing Cash Flow | $4.6M | +1608.1% |
| Free Cash Flow | -$8.7M | -112.8% |
| — |
| EPS (Basic) | -$7.13 | — |
| EPS (Diluted) | -$7.13 | — |
| Stockholders' Equity |
| -$5.7M |
| -125.5% |